Nuclear exclusion of p33ING1b tumor suppressor protein: explored in HCC cells using a new highly specific antibody

dc.citation.epage6en_US
dc.citation.issueNumber1en_US
dc.citation.spage1en_US
dc.citation.volumeNumber28en_US
dc.contributor.authorSayan, B.en_US
dc.contributor.authorEmre, N. C. T.en_US
dc.contributor.authorIrmak, M. B.en_US
dc.contributor.authorOzturk, M.en_US
dc.contributor.authorCetin Atalay, R.en_US
dc.date.accessioned2016-02-08T10:05:29Z
dc.date.available2016-02-08T10:05:29Z
dc.date.issued2009en_US
dc.departmentDepartment of Molecular Biology and Geneticsen_US
dc.description.abstractMouse monoclonal antibodies (MAb) were generated against p33ING1b tumor suppressor protein. 15B9 MAb was highly specific in recognizing a single protein band of ∼33 kDa endogenous p33ING1b protein from HCC cell lines and normal liver tissue by Western blot analysis and by immunoprecipitation. Although p33ING1b mutations are rarely observed in cancer, differential subcellular distribution and nuclear exclusion of p33ING1b were reported in different cancer types. Therefore we analyzed the expression and subcellular localization of p33ING1b in HCC cell lines using 15B9 MAb. So far, p33ING1b mutations or differential subcellular localization are not reported in HCC. In this study, by indirect immunofluorescence using MAb 15B9, we demonstrate that nuclear localization of p33ING1b was highly correlated with well-differentiated HCC cell lines whereas poorly differentiated HCC cells have nuclear exclusion of the protein. Moreover no association was observed between differential subcellular localization of p33ING1b and p53 mutation status of HCC cell lines. Hence our newly produced MAb 15B9 can be used for studying cellular activities of p33ING1b under normal and cancerous conditions. © Copyright 2009, Mary Ann Liebert, Inc.en_US
dc.description.provenanceMade available in DSpace on 2016-02-08T10:05:29Z (GMT). No. of bitstreams: 1 bilkent-research-paper.pdf: 70227 bytes, checksum: 26e812c6f5156f83f0e77b261a471b5a (MD5) Previous issue date: 2009en
dc.identifier.doi10.1089/hyb.2008.0058en_US
dc.identifier.issn1554-0014
dc.identifier.urihttp://hdl.handle.net/11693/22845
dc.language.isoEnglishen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.isversionofhttp://dx.doi.org/10.1089/hyb.2008.0058en_US
dc.source.titleHybridomaen_US
dc.subjectMonoclonal antibodyen_US
dc.subjectProtein p53en_US
dc.subjectTumor suppressor proteinen_US
dc.subjectUnclassified drugen_US
dc.subjectAnimal cellen_US
dc.subjectAnimal experimenten_US
dc.subjectAnimal tissueen_US
dc.subjectAntibody productionen_US
dc.subjectCancer cell cultureen_US
dc.subjectCell activityen_US
dc.subjectCell differentiationen_US
dc.subjectCellular distributionen_US
dc.subjectHuman cellen_US
dc.subjectImmunofluorescenceen_US
dc.subjectLiver cell carcinomaen_US
dc.subjectMouseen_US
dc.subjectMutationen_US
dc.titleNuclear exclusion of p33ING1b tumor suppressor protein: explored in HCC cells using a new highly specific antibodyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Nuclear exclusion of p33ING1b tumor suppressor protein Explored in HCC cells using a new highly specific antibody.pdf
Size:
10.52 MB
Format:
Adobe Portable Document Format
Description:
Full Printable Version